Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Abiomed, Inc. (NASDAQ: ABMD)

Tue Nov 20, 2012 11:46am EST

* Reuters is not responsible for the content in this press release.

  OKLAHOMA CITY, OK, Nov 20 (Marketwire) -- 
On November 16, 2012, a class action lawsuit was filed in the United
States District Court for the District of Massachusetts against Abiomed,
Inc. (NASDAQ: ABMD). The complaint alleges violations of federal
securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act
of 1934 and Rule 10b-5, including allegations of issuing a series of
material or false misrepresentations to the market which had the effect
of artificially inflating the market price during the Class Period, which
is August 5, 2011 through October 31, 2012.

    Plaintiff seeks to recover damages on behalf of all Abiomed, Inc.
shareholders who purchased common stock during the Class Period and are
therefore a member of the Class as described above. You may move the
Court no later than Tuesday, January 15, 2013 to serve as a lead
plaintiff for the entire Class. However, in order to do so, you must meet
certain legal requirements pursuant to the Private Securities Litigation
Reform Act of 1995.

    If you wish to discuss this action, obtain further information and
participate in this or any other securities litigation, or should you
have any questions or concerns regarding this notice or preservation of
your rights, please contact:


K. Lynn Nunn
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: kln@federmanlaw.com
Or, visit our website at www.federmanlaw.com 

Copyright 2012, Marketwire, All rights reserved.